PDX Model Cohort
Head & Neck CancerPDX Models (HNSCC)
Access one of the largest collections of clinically relevant head & neck cancer PDX models, expertly curated to assess the therapeutic potential of your novel drug candidates.
Summary
Champions' Head & Neck Cancer PDX Models represent a premier cohort designed to advance the discovery of breakthrough therapies for head and neck cancers. With one of the industry's largest banks of HNSCC models, this collection includes 125* Patient-Derived Xenograft (PDX) models that preserve critical clinical and molecular characteristics, mutation profiles, and pretreated models exposed to the latest cancer therapies, offering a powerful platform to evaluate the efficacy and therapeutic potential of drug candidates.
(*Model numbers fluctuate as our dataset continuously evolves.)
Champions' leading Head & Neck Cancer PDX models cohort showcases low-passage PDX models, each reflecting key clinical characteristics, and pretreatment history.
Access one of the largest banks of HNSCC models with clinically relevant molecularand pathological characteristics on the market.
Includes models pretreated with advanced cancer therapies and those resistant to targeted treatments and the latest immunotherapies targeting CDK4, PI3K, and EGFR.
Access to highly characterized HNSCC models with High Complexity Flow Cytometry, WES, RNAseq, Proteomics, and Phosphoproteomics.
Features models retaining key mutation profiles and clinical cancer characteristics, such as models that are HPV16+ and/or HPV18+.